Secor Alicia
SEC-identified person · CIK 1584516 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Zevra Therapeutics, INC. ZVRA | Director | filed 2025 - 2026 |
| G1 Therapeutics, Inc. GTHX | Director | filed 2021 - 2024 |
| Orchard Therapeutics plc ORTX | Director | filed 2020 - 2024 |
| GW Pharmaceuticals PLC GWPH | Director | filed 2018 - 2021 |
| Juniper Pharmaceuticals INC cbrx | Director · President and CEO | filed 2016 - 2018 |
| Zafgen, INC. ZFGN | Chief Commercial Officer | filed 2014 - 2016 |
| Trimeris INC TRMS | SVP, Chief Operating Officer | filed 2013 - 2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.